Visikol to Expand Facility to Meet Growing Demand
Hampton, NJ - Visikol has announced today that it has expanded its Hampton, NJ facility 11,000 sq ft through [...]
Visikol Launches Novel Blood Brain Barrier Assay
As a leading provider of advanced cell culture assays that works with all of the top twenty pharmaceutical companies, [...]
Visikol Commits to Automation in its 3D Cell Culture Center of Excellence
3D cell culture models provide the opportunity to better mimic the in vivo microenvironment, and thus better predict in [...]
Vivesto Signs Agreement with Visikol
Vivesto signs agreement with leading US CRO to evaluate anti-cancer drug formulations using its proprietary drug delivery platforms Solna, [...]
Visikol Partners with Molecular Instruments to Offer Hybridization Chain Reaction (HCR)-RNA FISH Multiplex Tissue Imaging Services
40X imaging of B-actin RNA with HCR RNA-FISH (red) and DAPI (blue) Hampton, NJ - Visikol has announced [...]
Visikol To Exhibit and Present at 2022 SOT
Visikol to Exhibit and Present at 2022 SOT Annual Meeting in San Diego Visit Visikol at booth 2018 at [...]
Visikol to Present at the 5th Annual Drug Discovery & Development Conference
Labroots Drug Discovery & Development 2022 Labroots and the Drug Discovery planning committee are pleased [...]
Visikol to Exhibit at SLAS2022
Visikol to Exhibit at SLAS2022 International Conference and Exhibition in Boston February 5-9, 2022 Visikol is excited to [...]
Visualizing the Benefits of 3D Cell Culture Webinar
Visualizing the Benefits of 3D Cell Culture Presented by Genetic Engineering & Biotechnology & Corning Broadcast Date: November 5, 2021 [...]